These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6145367)

  • 1. Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
    Johns VJ
    Am J Surg; 1984 Jun; 147(6):725-30. PubMed ID: 6145367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects.
    Frishman W; Silverman R
    Am Heart J; 1979 Jun; 97(6):797-807. PubMed ID: 34990
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG.
    Algra A; Roelandt JR; Tijssen JG; Simoons ML; Pool J
    Eur Heart J; 1987 Aug; 8 Suppl D():71-3. PubMed ID: 2890523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
    Frishman WH
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of beta adrenergic blocking drugs in cardiovascular disease.
    Prichard BN
    Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of beta adrenergic blockers.
    Kaul U; Wahi PL
    Indian J Chest Dis Allied Sci; 1980; 22(1):1-3. PubMed ID: 6111531
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking drugs and coronary heart disease.
    Goldstein S
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():219-25. PubMed ID: 9211014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and the heart. VII. Which drug for which disease?
    Opie LH
    Lancet; 1980 May; 1(8176):1011-7. PubMed ID: 6103335
    [No Abstract]   [Full Text] [Related]  

  • 14. The beta-adrenoceptor blocking drugs.
    Frishman WH
    Int J Cardiol; 1982; 2(2):165-78. PubMed ID: 6130045
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta blocking drugs as anti-arrhythmic agents.
    Fitzgerald JD
    Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):235-44. PubMed ID: 238912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias.
    Acanfora D; Pinna GD; Gheorghiade M; Trojano L; Furgi G; Maestri R; Picone C; Iannuzzi GL; Marciano F; Rengo F
    Am J Ther; 2000 Aug; 7(4):229-36. PubMed ID: 11486156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-Blockers in the management of myocardial ischemia.
    Davies RO
    Adv Cardiol; 1974; 13():315-29. PubMed ID: 4155918
    [No Abstract]   [Full Text] [Related]  

  • 19. Early arrhythmias following experimental coronary occlusion in conscious dogs and their modification by beta-adrenoceptor blocking drugs.
    Khan MI; Hamilton JT; Manning GW
    Am Heart J; 1973 Sep; 86(3):347-58. PubMed ID: 4146951
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.